Welcome to our dedicated page for CALERES SEC filings (Ticker: CAL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Caleres Inc. filings document the footwear company’s operating results, governance matters, executive-officer changes and capital-structure disclosures. Its Form 8-K reports include quarterly results furnished under Item 2.02 and leadership disclosures under Item 5.02, including principal financial and accounting officer appointments and departures.
Proxy materials cover annual meeting governance topics, board matters and executive compensation disclosures for the company. Filing records also identify Caleres common stock, par value $0.01 per share, listed on the New York Stock Exchange under the symbol CAL, along with material-event, material-agreement and capital-structure reporting relevant to the company’s public-company status.
THORN BRUCE K reported acquisition or exercise transactions in this Form 4 filing.
Caleres Inc. director Bruce K. Thorn received an equity award of 12,196 shares of Common Stock, valued at $13.12 per share. This is a grant of restricted stock as part of director compensation, not an open-market purchase. Following the grant, Thorn directly holds 36,647 shares. Vesting of the restricted stock is contingent on his continued service as a director through the next annual meeting of shareholders.
Freeman Brenda reported acquisition or exercise transactions in this Form 4 filing.
CALERES INC director Brenda Freeman received a grant of 12,196 restricted stock units (RSUs) on Common Stock. The RSUs were awarded at a reference fair market value of $13.12 per share and are a form of equity compensation rather than an open-market purchase or sale.
Each RSU represents a contingent right to receive the fair market value of one share of Caleres common stock. Vesting depends on her continued service as a director through the next annual meeting of shareholders, and the RSUs will be settled in shares of common stock when her board service ends or on another date she elects.
MILLARD WENDA HARRIS reported acquisition or exercise transactions in this Form 4 filing.
CALERES INC director Wenda Harris Millard received an equity grant of 12,196 restricted stock units. Each unit represents the fair market value of one share of Caleres common stock, with the grant valued at $13.12 per unit for accounting purposes.
The RSUs vest only if the director continues board service through the next annual meeting of shareholders. They will be settled in Caleres common shares when the director’s board service ends or on another date the director elects, making this a non-cash, stock-based compensation award.
KLEIN WARD M reported acquisition or exercise transactions in this Form 4 filing.
CALERES INC director Ward M. Klein received a grant of 12,196 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive the fair market value of one share of Caleres common stock, using a reference value of $13.12 per unit at grant.
The RSUs vest only if Klein continues serving as a director through the next annual meeting of shareholders. They will be settled in shares of common stock when his board service ends or on another date he elects, aligning his compensation with long-term shareholder interests.
Greeley Lori reported acquisition or exercise transactions in this Form 4 filing.
CALERES INC director Lori Greeley received a grant of 12,196 restricted stock units, each tied to one share of common stock. The grant is valued at $13.12 per unit based on the reported fair market value.
The units vest only if she continues serving as a director through the next annual shareholder meeting. They will be settled in shares of CALERES common stock when her board service ends or on another date she elects. This filing reflects a compensation-related equity award, with no share sales reported.
Gendreau Kyle reported acquisition or exercise transactions in this Form 4 filing.
CALERES INC director Kyle Gendreau received a grant of restricted stock units as equity compensation. On the reported date, he was awarded 12,196 restricted stock units tied to the company’s common stock at a reference value of $13.12 per unit.
Each unit represents a contingent right to the fair market value of one share, with vesting dependent on his continued board service through the next annual shareholder meeting. The units will be settled in shares of common stock when his service as a director ends or on another date he elects, so this filing reflects a non-cash, compensation-related equity award rather than an open-market stock purchase.
Caleres, Inc. reported stronger first-quarter results, with net sales rising to $666.6 million from $614.2 million, driven mainly by 20.6% growth in the Brand Portfolio segment, including contributions from the Stuart Weitzman acquisition. Famous Footwear sales declined 2.5% as store traffic softened in a tougher consumer environment.
Gross margin improved to 47.3% from 45.4%, helped by lower ongoing tariffs, mitigation efforts, lower markdowns and a better product mix. Operating earnings more than doubled to $23.9 million, and diluted EPS increased to $0.42 from $0.21. Caleres ended the quarter with $37.7 million in cash and $191.5 million of additional borrowing availability.
CALERES INC director Wenda Harris Millard exercised equity awards to acquire additional common shares. On the reported date, she converted 4,718 restricted stock units into 4,718 shares of Caleres common stock, with no open-market purchase or sale involved.
Following the exercise, Millard directly holds 47,021 shares of Caleres common stock. The filing also shows that the related restricted stock unit position was reduced to zero, reflecting a compensation-related conversion rather than a discretionary trade.
Caleres, Inc. reported strong first quarter 2026 results, with net sales of $666.6 million versus $614.2 million a year ago and GAAP diluted earnings per share of $0.42, up from $0.21. Adjusted diluted earnings per share were $0.38, which the company said exceeded its guidance.
Gross profit rose to $315.5 million from $278.7 million, and operating earnings more than doubled to $23.9 million. Brand Portfolio drove growth, while Famous Footwear saw lower sales and comparable sales. Caleres guided to mid-to-high-single-digit net sales growth and GAAP EPS of $0.32 to $0.38 for second quarter 2026, and full-year 2026 GAAP EPS of $1.44 to $1.69 with gross margin expansion.
Caleres Inc Chief Sourcing Officer Daniel R. Freidman reported an open-market sale of 11,207 shares of Caleres common stock at $15.00 per share on May 28, 2026. The filing notes the sale was executed under a Rule 10b5-1 trading plan adopted on December 16, 2025, indicating it was pre-arranged. Following the sale, Freidman directly owns 64,780 common shares and indirectly holds 7,443 shares through a 401(k) plan.